Amicus Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
YU JULIE officer: VP Clinical Ops & Data..
 Stock Options (right to buy) 3,200 $3.53 $11,296
Option
CASTELLI JEFF officer: SVP, Program Management
 Stock Options (right to buy) 8,552 $1.41 $12,016
Purchase
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 10,000 $3.53 $35,300
Sale
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 3,200 $3.53 $11,296
Purchase
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 3,200 $3.53 $11,296
Option
PEIST KENNETH officer: VP, Legal & IP
 Stock Options (right to buy) 13,853 $3.53 $48,901
Sale
CASTELLI JEFF officer: SVP, Program Management
 Common stock 8,552 $7 $59,864
Sale
QUIMI DAPHNE officer: Chief Financial Officer
 Common stock 6,812 $7 $47,684
Purchase
CASTELLI JEFF officer: SVP, Program Management
 Common stock 8,552 $7 $59,864
Option
CASTELLI JEFF officer: SVP, Program Management
 Stock Options (right to buy) 10,208 $2.52 $25,724
Purchase
CASTELLI JEFF officer: SVP, Program Management
 Common stock 10,208 $2.52 $25,724
Option
YU JULIE officer: VP Clinical Ops & Data..
 Stock Options (right to buy) 4,759 $1.26 $5,996
Sale
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 4,759 $5.99 $28,516
Sale
CASTELLI JEFF officer: SVP, Program Management
 Common stock 10,208 $2.52 $25,724
Purchase
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 4,759 $5.99 $28,516
Sale
PEIST KENNETH officer: VP, Legal & IP
 Common stock 28,208 $6.09 $171,815
Purchase
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 25,311 $6.09 $154,119
Option
PEIST KENNETH officer: VP, Legal & IP
 Stock Options (right to buy) 20,208 $1.26 $25,462
Option
QUIMI DAPHNE officer: Chief Financial Officer
 Stock Options (right to buy) 10,738 $1.26 $13,530
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
 Stock Options (right to buy) 25,311 $1.26 $31,892
Purchase
QUIMI DAPHNE officer: Chief Financial Officer
 Common stock 10,738 $6.1 $65,470
Purchase
PEIST KENNETH officer: VP, Legal & IP
 Common stock 28,208 $6.09 $171,815
Sale
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 25,311 $6.09 $154,119
Sale
QUIMI DAPHNE officer: Chief Financial Officer
 Common stock 10,738 $6.1 $65,470
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Stock Options (right to buy) 5,000 $3.32 $16,600
Purchase
SBLENDORIO GLENN director
 Common stock 10,000 $2.81 $28,100
Option
SBLENDORIO GLENN director
 Stock Options (right to buy) 10,000 $2.81 $28,100
Purchase
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 5,000 $3.32 $16,600
Sale
SBLENDORIO GLENN director
 Common stock 10,000 $2.81 $28,100
Sale
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 5,000 $3.32 $16,600
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Stock Options (right to buy) 7,000 $3.53 $24,710
Sale
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 7,000 $3.53 $24,710
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Stock Options (right to buy) 5,000 $3.32 $16,600
Purchase
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common stock 7,000 $3.53 $24,710
Sale
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 12,450 $6 $74,700
Sale
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 5,000 $3.32 $16,600
Option
DILONE ENRIQUE officer: SVP, Technical Operati..
 Stock Options (right to buy) 7,000 $3.53 $24,710
Purchase
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 12,450 $4.41 $54,842
Purchase
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 5,000 $3.32 $16,600
Purchase
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 7,000 $3.53 $24,710
Sale
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common srock 7,000 $3.53 $24,710
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Stock Options (right to buy) 12,450 $4.41 $54,842
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Stock Options (right to buy) 6,080 $2.81 $17,085
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Stock Options (right to buy) 7,000 $2.81 $19,670
Sale
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 6,080 $2.81 $17,085
Purchase
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common stock 12,810 $4.36 $55,852
Sale
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 18,750 $2.81 $52,688
Purchase
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 6,080 $2.81 $17,085
Purchase
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 7,000 $2.81 $19,670
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Stock Options (right to buy) 18,750 $2.81 $52,688

Showing 950 to 1000 of 1301 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: